1.236 artigos
A multimodal AI tool combining echo data, lab work, and clinical markers outperforms older models at catching a deadly, underdiagnosed heart condition.
XPRIZE Healthspan pits 10 teams against each other to restore muscle, cognition, and immunity in older adults by 2030.
A obesity medicine physician explains why GLP-1 microdosing is unsupported by data and potentially risky for cosmetic weight loss seekers.
A new class of drugs called proximity degraders can destroy disease-causing proteins once considered untreatable. Here's what's coming next.
Harvard Health Publishing releases 'Pathways to Longevity,' introducing aging science, hallmarks, and emerging therapies to general readers.
A new joint venture completes a key manufacturing step for a cell therapy designed to restore α-Klotho, a protein linked to aging and disease.
Ribo's RBD1119 aims to cut thrombotic risk in heart disease patients where current blood thinners fall short.
A rebranded AI lab is training disease models on massive brain datasets to speed up drug discovery for neurological conditions.
A new AI health modeling company pairs vast multi-omic datasets with Insilico Medicine's deep learning to accelerate longevity research.
Scribe Therapeutics reports a one-time epigenetic therapy slashed LDL cholesterol up to 68% for nearly two years in primates.
New research links sleep complaints in women over 65 with tau buildup and visual memory decline, pointing to sleep as an early Alzheimer's warning sign.
New Nature studies reveal the thymus remains a critical organ in adult health, predicting mortality, cardiovascular, and cancer outcomes.
